These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 14562517)

  • 41. p53: from molecular mechanisms to prognosis in cancer.
    Fung CY; Fisher DE
    J Clin Oncol; 1995 Apr; 13(4):808-11. PubMed ID: 7707105
    [No Abstract]   [Full Text] [Related]  

  • 42. The future of cancer therapy: an interview with Gerard Evan.
    Evan G
    Dis Model Mech; 2008; 1(2-3):90-3. PubMed ID: 19048069
    [TBL] [Abstract][Full Text] [Related]  

  • 43. p53 analysis in diagnostic pathology. Biologic implications and possible clinical applications.
    Yandell DW; Thor AD
    Diagn Mol Pathol; 1993 Mar; 2(1):1-3. PubMed ID: 8287220
    [No Abstract]   [Full Text] [Related]  

  • 44. Mutant p53 mediates survival of breast cancer cells.
    Lim LY; Vidnovic N; Ellisen LW; Leong CO
    Br J Cancer; 2009 Nov; 101(9):1606-12. PubMed ID: 19773755
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heat shock factor 1 deficiency via its downstream target gene alphaB-crystallin (Hspb5) impairs p53 degradation.
    Jin X; Moskophidis D; Hu Y; Phillips A; Mivechi NF
    J Cell Biochem; 2009 Jun; 107(3):504-15. PubMed ID: 19343786
    [TBL] [Abstract][Full Text] [Related]  

  • 46. p53 regulates Hsp90beta during arsenite-induced cytotoxicity in glutathione-deficient cells.
    Habib GM
    Arch Biochem Biophys; 2009 Jan; 481(1):101-9. PubMed ID: 18996350
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
    Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V
    Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conference report--at the forefront of cancer research: preclinical data highlights of annual meeting of the 95th American Association for Cancer Research; March 27-31, 2004; Orlando, Florida.
    Mariani SM
    MedGenMed; 2004 May; 6(2):18. PubMed ID: 15266244
    [No Abstract]   [Full Text] [Related]  

  • 49. Drifting downstream.
    Brooksbank C
    Nat Rev Cancer; 2002 Feb; 2(2):79. PubMed ID: 12635167
    [No Abstract]   [Full Text] [Related]  

  • 50. Controlling apoptosis: implications for carcinogenesis?
    Clarke AR
    Symp Soc Exp Biol; 2000; 52():265-75. PubMed ID: 12090014
    [No Abstract]   [Full Text] [Related]  

  • 51. Teaching resource. Canonical Wnt/beta-catenin signaling.
    Moon RT
    Sci STKE; 2004 Jun; 2004(240):tr5. PubMed ID: 15240898
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The p53 saga: the good, the bad, and the dead.
    Oren M
    Harvey Lect; 2001-2002; 97():57-82. PubMed ID: 14562517
    [No Abstract]   [Full Text] [Related]  

  • 53. Decision making by p53: life, death and cancer.
    Oren M
    Cell Death Differ; 2003 Apr; 10(4):431-42. PubMed ID: 12719720
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.